Simone Tambaro
Solna, AB 17177, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
D-chiro-inositol modulates brain insulin-related signaling and reduces amyloid burden, neuroinflammation and cognitive decline in preclinical models of Alzheimer's disease.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 30, 2026
Timeless and Stainless Alcohol: Concentric Waves from Its Oxidative Metabolism and Related Oxidative Stress.
Journal: Antioxidants (Basel, Switzerland)
Published: December 09, 2025
Cell Type-Specific Expression of p16, p21, and p53 Reveals Age-Dependent Glial Senescence in the AppNL-G-F Mouse Model of Alzheimer's Disease.
Journal: Aging cell
Published: October 21, 2025
Nerve growth factor responsive elements modulate immune cell inflammation and are dysregulated in an Alzheimer's disease mouse model.
Journal: Frontiers in immunology
Published: October 10, 2025
Emerging Pro-neurogenic Therapeutic Strategies for Neurodegenerative Diseases: A Review of Pre-clinical and Clinical Research.
Journal: Molecular neurobiology
Published: January 03, 2024
Signal peptide peptidase-like 2b modulates the amyloidogenic pathway and exhibits an Aβ-dependent expression in Alzheimer's disease.
Journal: Progress in neurobiology
Published: June 30, 2023
The Expression of the Endocannabinoid Receptors CB2 and GPR55 Is Highly Increased during the Progression of Alzheimer's Disease in AppNL-G-F Knock-In Mice.
Journal: Biology
Published: March 15, 2023
Feasibility and therapeutical potential of local intracerebral encapsulated cell biodelivery of BDNF to AppNL-G-F knock-in Alzheimer mice.
Journal: Alzheimer's research & therapy
Published: January 30, 2023
Translational potential of synaptic alterations in Alzheimer's disease patients and amyloid precursor protein knock-in mice.
Journal: Brain communications
Published: February 21, 2022
Autophagy Impairment in App Knock-in Alzheimer's Model Mice.
Journal: Frontiers in aging neuroscience
Published: February 17, 2022
Intravenous treatment with a molecular chaperone designed against β-amyloid toxicity improves Alzheimer's disease pathology in mouse models.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 03, 2022
Last Updated: 09/26/2026